MDT perspectives on approaches for the use of immune checkpoint inhibitor therapy in patients with solid tumours
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.
The multidisciplinary team:
Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK
Clinical oncology pharmacist: Dr Alison Palumbo, Oregon Health and Science University, Oregon, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.